Knockdown of CCL2 via siRNA inhibited cell proliferation and angiogenesis in the glioma cell line U251 in vitro (Lu et al., 2017) while overexpression in a U87 glioma cell line increased invasiveness, dependent on presence of CCR2-expressing microglia (Zhang et al., 2012). The gene discussed is CCL2; the disease is central nervous system cancer.